Accelerated alveolar bone loss in a mouse model of inflammatory bowel disease and its relationship with intestinal inflammation
- 29 January 2022
- journal article
- research article
- Published by Wiley in Journal of Periodontology
- Vol. 93 (10) , 1566-1577
Abstract
Background: Bone loss is a common complication of inflammatory bowel disease (IBD); however, few studies have focused on alveolar bone loss (ABL) in IBD. Herein, we systematically observed ABL in an interleukin (IL)‐10 knockout (IL‐10–/–) mouse model of IBD and explored the possible mechanisms.Methods: IL‐10–/– and age‐matched wild‐type (WT) male mice were sacrificed every 2 weeks from 12 to 24 weeks of age. ABL was determined by microcomputed tomography. Periodontal and intestinal inflammation were evaluated using histological grading and inflammatory factor expression levels. Intestinal barrier integrity and cytokine levels in serum were examined by immunofluorescence and enzyme‐linked immunosorbent assays, respectively. The expression of macrophage phenotype markers, including inducible nitric oxide synthase (iNOS), arginase‐1 (Arg‐1), and bone metabolic markers, including osteoprotegerin, receptor activator of nuclear factor‐κB ligand (RANKL), were measured by immunohistochemistry. The macrophage phenotype in the periodontium was also examined by real‐time quantitative polymerase chain reaction.Results: Compared with WT mice, IL‐10–/– mice exhibited significant ABL from 18 weeks of age. However, no significant differences were observed in the periodontium between the two groups in either histopathological scores or inflammatory factor levels. In the colon and ileum, these measurements significantly increased in IL‐10–/– mice from 12 and 14 weeks, respectively. Correlation analysis also revealed that ABL in IL‐10–/– mice was positively correlated with intestinal inflammation. Furthermore, IL‐10–/– mice showed a destroyed intestinal barrier and higher serum levels of inflammatory factors. In both the intestine and periodontium, higher iNOS and lower Arg‐1 levels, along with an increase in RANKL expression in the periodontium, were examined in IL‐10–/– mice.Conclusions: An accelerated ABL spontaneously occurred in IL‐10–/– mice and was correlated more with inflammation of the intestine than periodontium. Immunopathological changes may be the potential cause of abnormal alveolar bone metabolism.Keywords
This publication has 46 references indexed in Scilit:
- Inflammatory Bowel DiseaseAnnual Review of Immunology, 2010
- Down‐regulation of expression of osteoblast and osteocyte markers in periodontal tissues associated with the spontaneous alveolar bone loss of interleukin‐10 knockout miceEuropean Journal of Oral Sciences, 2010
- Osteoporosis in Inflammatory Bowel DiseaseThe American Journal of Medicine, 2009
- Dextran sodium sulfate-induced colitis causes rapid bone loss in miceBone, 2008
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Three‐Dimensional Micro‐Computed Tomographic Imaging of Alveolar Bone in Experimental Bone Loss or RepairJournal of Periodontology, 2007
- Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case–control studyJournal of Clinical Periodontology, 2006
- CD4 + CD45RB Hi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerinGut, 2004
- Effect of Crohn's Disease on Bone Metabolism In Vitro: A Role for Interleukin-6Journal of Bone and Mineral Research, 2002
- Prevalence and severity of periodontal disease in patients with inflammatory bowel diseaseJournal of Clinical Periodontology, 1991